Antonio C. H.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of Ripretinib on Pharmacokinetics of Midazolam in Patients with Advanced Gastrointestinal Stromal Tumor
- Phase IIb/III Randomized Controlled Study of Lurbinectedin Plus Doxorubicin Versus Doxorubicin Monotherapy in Metastatic Leiomyosarcoma Patients
- Phase 3 Randomized Study of Pembrolizumab and Lenvatinib Versus Chemotherapy in Advanced or Recurrent Endometrial Carcinoma
Data & Insights
Has run more than one trial at 130 of 280 partner sites.
Specializations
Sarcoma Specialization
This investigator demonstrates significant expertise in treating various forms of soft tissue sarcomas, with particular focus on advanced and metastatic cases. Their research encompasses both conventional chondrosarcoma and gastrointestinal stromal tumors (GIST).
- Advanced L-sarcomas
- Non L-sarcomas
- Conventional chondrosarcoma
The investigator's work extends to evaluating novel therapeutic approaches for both localized and metastatic sarcoma presentations.
Combined Therapy Approaches
The investigator explores innovative therapeutic combinations, particularly focusing on the integration of radiotherapy with novel pharmaceutical interventions. Their research includes investigation of different treatment schedules and dosing regimens.
- Radiotherapy combinations
- Advanced solid tumors
- Palliative treatment approaches
Their work encompasses both curative and palliative treatment strategies for various tumor types.
Clinical Assessment Methods
The investigator utilizes sophisticated clinical assessment methodologies, including progression-free survival evaluation and response rate measurements. Their research incorporates advanced imaging and independent review processes.
- Tumor response evaluation
- Progressive disease assessment
- Treatment efficacy monitoring
Expertise includes the implementation of standardized response criteria and independent radiological review processes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
